Christopher A.Buxton (Chris)


达拉斯 + 1.214.969.4841

Chris Buxton focuses his practice on intellectual property, with an emphasis on patent and trade secret litigation. He has represented clients before U.S. district courts and the Patent Trial and Appeal Board (PTAB) in matters across a variety of industries, including medical devices, pharmaceuticals, wireless communications, semiconductor devices, field-programmable gate arrays (FPGAs), cryptography, natural language processing, automotive repair, building products, and digital rights management (DRM).

Chris has drafted case dispositive motions before federal courts and has argued successfully in Markman hearings for key claim constructions. He also has extensive experience working with fact and expert witnesses to develop testimony and expert opinions, taking and defending depositions, coordinating discovery, and conducting prelitigation investigations.

Chris also maintains an active pro bono practice and has assisted Latin American refugees seeking asylum in the United States through the Firm's Border Project.


  • Xilinx defeats all infringement claims brought by WSOU Investments asserting Alcatel-Lucent patent portfolioJones Day successfully defended Xilinx, Inc. against five patent infringement cases filed by plaintiff WSOU d/b/a Brazos asserting Alcatel-Lucent patents related to optical networks, power management, and clock generation.
  • Charles Schwab exits patent dispute brought against several financial institutions in E.D. Tex.Jones Day defended Charles Schwab & Co. against patent infringement claims brought against several financial institutions in the Eastern District of Texas before Judge Rodney Gilstrap.
  • Charles Schwab Bank resolves infringement claims involving fintech patentsJones Day defended Charles Schwab Bank in a patent infringement case before Judge Alan Albright in the Western District of Texas involving fintech technology.
  • Hope Pharmaceuticals files two IPR petitions challenging all claims of two Fennec patents relating to sodium thiosulfateJones Day represents Hope Medical Enterprises, Inc. ("Hope Pharmaceuticals") in two petitions for inter partes review ("IPR") at the United States Patent Office's Patent Trial and Appeal Board ("PTAB").
  • Wells Fargo provides $87.5 million senior secured revolving credit facility to Florida-based homebuilderJones Day represented Wells Fargo Bank, National Association, as administrative agent, in connection with a $87.5 million senior secured revolving credit facility provided to a Florida-based homebuilder.
  • Seal for Life acquires Flame Control Coatings, Highland International, LifeLast, and US CoatingsJones Day advised Arsenal Capital Partners ("ACP") on the four acquisitions by portfolio company Seal for Life of Flame Control Coatings, Highland International, LifeLast, and US Coatings, manufacturers of protective coating technologies.
  • Callfire resolves patent litigation relating to Interactive Voice Response technologyJones Day defended Callfire, Inc. against allegations that its Interactive Voice Response system infringed a patent relating to audio communications.
  • NEC defends against patent infringement lawsuit relating to ten telecommunications network systems patentsJones Day is defending NEC Corporation in a litigation brought by Far North Patents, LLC in the Eastern District of Texas, in which the plaintiff is accusing NEC's telecommunications network management systems of infringing ten patents covering an array of networking related technologies.